Post Profile

Making medications safer for newborns

(Wiley) Although new drugs must be shown to be both safe and effective for approval by the Food and Drug Administration, sick newborns receive most of their drug treatment off-label and without the evidence provided for adults and older children. A new editorial looks at the challenges of performing clinical trials in newborns, from the reluctance of parents to enroll their infants to the lack of experience of pediatricians and neonatologists in conducting clinical research.
read more

See more about: Drug Administration

Related Posts

Study Shows Combination Drug Therapy for Asthma Patients Is Safe

Health : Newswise Medical News

A post-marketing safety study mandated by the U.S. Food and Drug Administration has shown that a combination drug therapy for the treatment of asthma is safe and effective.

Medical News Today: World's first 3D-printed drug approved by FDA

Health : Medical News Today

The world's first drug developed using 3D-printing technology has received approval from the Food and Drug Administration for the treatment of epilepsy.

Potiga (ezogabine) Tablets Approved For Seizure In Adults As Add-On Medication

Health : Medical News Today

The US Food and Drug Administration (FDA) has approved anticonvulsant Potiga (ezogabine) tablets as an add-on drug for the treatment of partial seizures in adults with epilepsy. The active ingredient was approved by EMA (European Me...

FDA’s ‘safe and effective’ drug approvals based on widely varied data, study finds

Health : The Checkup

The Food and Drug Administration must bless any new drugs as “safe and effective” before they wind up in pharmacy aisles or prescribed to patients. But the ways in which the agency arrives at those approvals “vary widely in their th...

Cedars-Sinai Receives Approval to Test Novel Combined Stem Cell and Gene Therapy for ALS Patients

Health : Newswise Medical News

Cedars-Sinai regenerative medicine investigators have received approval from the U.S. Food and Drug Administration to test a combination stem cell-gene therapy they developed to stall the progression of amyotrophic lateral sclerosis...


Copyright © 2016 Regator, LLC